Edition:
United Kingdom

People: Accelerate Diagnostics Inc (AXDX.OQ)

AXDX.OQ on NASDAQ Stock Exchange Capital Market

18.75USD
22 Jul 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$18.75
Open
$18.75
Day's High
$19.06
Day's Low
$18.70
Volume
38,356
Avg. Vol
71,275
52-wk High
$24.70
52-wk Low
$10.25

Patience, John 

Mr. John Patience is Independent Chairman of the Board of Accelerate Diagnostics Inc. since June 26, 2012. Mr. Patience is also a founding partner of Crabtree Partners, a private equity investment firm. Mr. Patience served as a director of Ventana Medical Systems, Inc. from 1989 and as Vice Chairman from 1999 until Ventana’s acquisition by Roche in 2008. Mr. Patience has been a director of Stericycle, Inc. (NASDAQ: SRCL) since 1989. Mr. Patience was previously a partner of a venture capital investment firm that provided both Ventana and Stericycle with early stage funding. Mr. Patience was also previously a partner in the consulting firm of McKinsey & Co. Inc. specializing in health care. Mr. Patience holds a B.A. in Liberal Arts and an L.L.B. from the University of Sydney, Australia, and an M.B.A. from the University of Pennsylvania’s Wharton School of Business.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 161,802
Fiscal Year Total, USD 161,802

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Patience

161,802

Lawrence Mehren

375,000

Steve Reichling

694,800

Ron Price

871,188

Thomas Brown

767,025

Mark Miller

161,802
As Of  31 Dec 2017